TechNavio's analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 4.06 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing uptake of biologics. The Global Psoriasis Therapeutics market has also been witnessing an increased focus on using combination therapies for treating psoriasis. However, the adverse side effects associated with psoriatic drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Psoriasis Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Amgen Inc., Pfizer Inc., Janssen Biotech Inc., and Abbvie Inc.
The other vendors mentioned in the report are AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG
UCB S.A. Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
04. Market Research Methodology
Market Research Process
05. Scope of the Report
06. Types of Psoriasis
06.1 Types of Psoriasis Based on Forms
06.2 Types of Psoriasis Based on Severity of Disease
07. Market Landscape
07.1 Global Psoriasis Therapeutics Market
Market Size and Forecast
07.2 Global Mild Psoriasis Therapeutics Market
07.3 Global Moderate Psoriasis Therapeutics Market
07.4 Global Severe Psoriasis Therapeutics Market
07.5 Five Forces Analysis
08. Geographical Segmentation
09. Rate of Incidence and Prevalence
Global Incidence and Prevalence
10. Pipeline Analysis
10.1 Topical Treatment Pipeline Analysis
10.2 Oral Treatment Pipeline Analysis
10.3 Injectable Treatment Pipeline Analysis
11. Vendor Landscape
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Key Vendor Analysis
18.1 Abbvie Inc.
18.2 Amgen Inc.
18.3 Janssen Biotech Inc.
18.4 Novartis International AG
18.5 Pfizer Inc.
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Psoriasis Based on Forms
Exhibit 3: Types of Psoriasis Based on Severity of Disease
Exhibit 4: Types of Psoriasis Based on Severity of Disease 2012
Exhibit 5: Global Psoriasis Therapeutics Market 2012-2016 (US$ billion)
Exhibit 6: Global Mild Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 7: Global Moderate Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 8: Global Severe Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 9: Global Psoriasis Therapeutics Market by Geographical Segmentation 2012
Exhibit 10: Business Segmentation of Novartis International AG
Exhibit 11: Business Segmentation of Pfizer Inc.